Skip to content
Trending storyDeveloping

Kindeva lands $226M defense contract to supply nerve agent antidote in US - Fierce Pharma

1 report1 sourceupdated 14 hours ago

Start here

No synthesis yet — start with the coverage timeline below.

Coverage timeline

Follow the coverage to see the different angles.

Heat trend for this story

Not enough continuous observation yet to draw a trend.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org